AvalehtMEHCQ • OTCMKTS
add
23andMe Holding Co.
Viimane sulgemishind
1,21 $
Tänane vahemik
1,18 $ - 1,29 $
Aasta vahemik
0,48 $ - 12,76 $
Turuväärtus
32,73 mln USD
Keskmine maht
8,10 mln
P/E suhe
-
Dividendimäär
-
Põhibörs
OTCMKTS
Uudised
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
| (USD) | dets 2024info | Y/Y muutus |
|---|---|---|
Käive | 60,26 mln | 34,67% |
Põhitegevusega seonduv kulu | 65,06 mln | −22,18% |
Puhastulu | −53,04 mln | 80,92% |
Puhaskasumimarginaal | −88,01 | 85,83% |
Puhaskasum aktsia kohta | — | — |
EBITDA | −21,80 mln | 62,70% |
Tõhus maksumäär | — | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
| (USD) | dets 2024info | Y/Y muutus |
|---|---|---|
Sularaha ja lühiajalised investeeringud | 79,35 mln | −67,27% |
Kogu vara | 277,42 mln | −54,39% |
Kõik kohustused | 214,70 mln | −7,06% |
Kogu omakapital | 62,72 mln | — |
Emiteeritud aktsiate arv | 26,83 mln | — |
Hinna ja väärtuse suhe P/B | 0,51 | — |
Varade tasuvus | −21,15% | — |
Kapitali tasuvus | −42,49% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
| (USD) | dets 2024info | Y/Y muutus |
|---|---|---|
Puhastulu | −53,04 mln | 80,92% |
Põhitegevuse rahakäive | −44,65 mln | −270,23% |
Investeeringute raha | 887,00 tuh | 144,09% |
Finantseerimise raha | −19,00 tuh | −118,10% |
Raha ja raha ekvivalentide muutus | −43,79 mln | −213,47% |
Tasuta rahavoog | −20,18 mln | −469,10% |
Teave
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Asutatud
apr 2006
Veebisait
Töötajate arv
571
